Form 8-K · Current Report · Filed 2026-02-05
The Cigna Group Announces 2025 Results and Increases 2026 Dividend
The Cigna Group reported a strong financial performance for 2025 with total revenues increasing by 11% to $274.9 billion, shareholders' net income at $6.0 billion, or $22.18 per share, and adjusted income from operations at $8.0 billion, or $29.84 per share.
- Filer
- The Cigna Group CI · NYSE
- Filed
- Accession
- 0001140361-26-003768
- CIK
- 0001739940
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
The company also announced an increase in the quarterly dividend to $1.56 per share for 2026, effective March 19, 2026.
Items reported
Reported Item
Market reaction
Close before filing
$271.71
Next session
+7.5%
Since filing
+2.7%
Latest close
$279.05
What happened, not what will happen — closing prices around the filing date.
About The Cigna Group
The Cigna Group is a leading global health services organization. Ranging across a comprehensive spectrum of health and wellness services, the company aims to improve the health, well-being, and peace of mind of those it serves. Notably, Cigna offers medical, dental, disability, life, and accident insurance coverage to individuals and businesses, extending its reach from individual clients to multinational corporations. Its primary business comprehends a vast network within the managed care sector, focusing on providing accessible and affordable healthcare solutions to its users. Cigna’s influence spans multiple sectors including health insurance, pharmacy benefit management, and behavioral health, highlighting its diverse portfolio. The company plays a crucial role in the health insurance market, consistently driving innovation in healthcare solutions and cost management. Its ability to integrate health services and provide holistic care solutions is pivotal in addressing the evolving needs of the healthcare landscape globally."}
Never miss another CI filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.